SARS-CoV-2 & ASCO Guidelines: Are Pts With Cancer More Likely to Be Infected & Do They Have More Complications? What About the Impact on Clinical Trials?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

SARS-CoV-2 & ASCO Guidelines: Are Pts With Cancer More Likely to Be Infected & Do They Have More Complications? What About the Impact on Clinical Trials?

By Stanford Medicine FEATURING Vineeta Agarwala

696 views

May 6, 2020

1 Comment

ESMO 2022 Congress Highlights: Hematological Malignancies

Feat. I. Glimelius

04:32

Stanford Medicine

DEA Guidelines for Prescribing During COVID-19: How Do You Continue …

Feat. S. Pritzlaff

06:51

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy of COVID Vaccinations in Patient…

Feat. K. Rogers

13:03

Stanford Medicine

COVID-19 Pain Management Best Practices: How to Prioritize Procedure…

Feat. S. Pritzlaff, M. Leong, R. Prasad

06:39

University of Miami Sylvester Comprehensive Cancer Center

COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifyin…

Feat. G. Lopes

15:15

Penn Medicine Abramson Cancer Center

Update on Treatment and Prevention of COVID-19 in Cancer Patients

Feat. A. Garfall

16:52

AstraZeneca Oncology

Prioritizing Early Diagnosis of Lung Cancer and Challenges During th…

Feat. N. Hanna, M. Pritchett

15:41

ERIC 2022 - European Research Initiative on CLL - ERIC

Outcomes of Patients With CLL and COVID-19 Infection

Feat. T. Chatzikonstantinou

33:56

Indy Hematology Review

Non-Malignant Hematology: What Have We Learned in 2022

Feat. C. Kessler

09:06

James Bussel

COVID-19, Thrombocytopenia & ITP: What is the Effect on Platelet…

20:35

Total Health

Lung Cancer and COVID-19 Updates

Feat. S. Richey

10:12

Memorial Sloan Kettering Cancer Center

Perspectives on COVID-19 and Multiple Myeloma Care: New York City, E…

Feat. O. Landgren

09:57

ASCO 2022 Conference Coverage

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

Feat. C. Dang

ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 Congress Highlights: Hematological Malig…

Feat. I. Glimelius

08:38

ASH 2021 Conference Coverage on VuMedi

ASH 2021 Clinical Predictors of Outcomes in Adult Acute Leukemias an…

Feat. P. Desai

21:57

Platelet Disorder Support Association (PDSA)

COVID-19 & ITP Updates

Feat. T. Gernsheimer

37:56

ASH 2022 Conference Coverage

Updates on Thrombosis & COVID-19

Feat. B. Hunt

15:48

Melvin Chua

SARS-CoV-2 Transmission in Cancer Patients: Is the Risk the Same for…

74:14

AstraZeneca Oncology

Lung Cancer Diagnosis and Patient Management During the COVID-19 Pan…

Feat. D. Hogarth, G. Cumbo-Nacheli, G. T Lam, A. Moriarity

68:24

AstraZeneca Oncology

Continuing Lung Cancer Diagnosis, Workup, & Care Across the Spec…

Feat. G. Cumbo-Nacheli, J. Gorden, B. Stiles

Login

Login

Join VuMedi

SARS-CoV-2 & ASCO Guidelines: Are Pts With Cancer More Likely to Be Infected & Do They Have More Complications? What About the Impact on Clinical Trials?

Related Content